Vital Signs - The Analyst's Perspective - June 2015 Issue

USD 450

* Required Fields

USD 450

PAY BY INVOICE

Be the first to review this product

This issue of Vital Signs, released in July 2015, discusses Affmetrix's acquisition of Eureka Genomics, OPKO Health's acquisition of Bio-Reference Laboratories, CVS Health's acquisition of Target's in-store pharmacies and clinics, and Thermo Fisher Scientific's acquisition of Alfa Aesar.

Table of Contents

Vital Signs - The Analyst's Perspective - June 2015 IssueVital Signs - June 2015 IssueThis month's issue




Related Research

Release Date : 11-Oct-17

Region : Asia Pacific

Release Date : 13-Jul-17

Region : Asia Pacific

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.